Login to Your Account

Other news to note

Wednesday, May 14, 2014

Gloria Pharmaceuticals Co., of Beijing, and Cumberland Pharmaceuticals Inc., of Nashville, Tenn., formed a joint R&D initiative. Each company has made a $1 million investment in Cumberland Emerging Technologies (CET), which is majority-owned by Cumberland and partnered with academic research centers to develop promising biopharmaceutical technologies.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription